GREGORY LANG: Open Payments
NPI 1023369527 · BEND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,500 in 18 payments from 10 companies in 2025. Trend: 2023 $1,006 · 2024 $698 · 2025 $1,500
Consulting: $780Food & beverage: $720
| Company | Payments | Amount |
|---|---|---|
| Esperion Therapeutics, Inc. | 2 | $878 |
| Amgen Inc. | 1 | $147 |
| Ionis Pharmaceuticals, Inc. | 1 | $107 |
| Novartis Pharmaceuticals Corporation | 5 | $103 |
| Regeneron Healthcare Solutions, Inc. | 1 | $92 |
| E.R. Squibb & Sons, L.L.C. | 4 | $77 |
| Abbott Laboratories | 1 | $37 |
| Novo Nordisk Inc | 1 | $23 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: NEXLIZET, LEQVIO, NEXLETOL, EVKEEZA, CAMZYOS, AVEIR, ELIQUIS, Wegovy.
Industry payments across OR — which companies pay providers there.
